Cost to borrow UMC shares has hit a record high. It jumped from 1.76% to 25.1% in seven days — a 1,329% rise. That is the sharpest move in the stock's history on ORTEX data.
The spike is happening even as short sellers exit. Short interest fell 12.1% over the same week to 24.8 million shares. Fewer shorts remain, but the remaining positions are now extraordinarily expensive to hold.
Availability has swung sharply. It stood at roughly 75% a week ago — tight, but manageable. It surged to 211% on July 8. That means more than two shares are now available to borrow for every one already lent out.
That loosening sounds contradictory alongside a record-high borrow cost. It likely reflects rapid repositioning. Short sellers returned shares quickly. The lending pool temporarily expanded relative to the smaller remaining short base. But prime brokers did not pass on lower rates — they repriced the risk of holding a position in a stock that moved 25% in a month.
The options market is picking up the same signal. The put-call ratio hit 0.3708 on July 8. That is 2.77 standard deviations above the 20-day mean of 0.25. It is a two-week high.
In isolation, a PCR of 0.37 is not extreme — the 52-week high is 1.04. But the z-score matters. The move is statistically significant against recent norms. Options traders are buying more downside protection than they have in weeks, even as the stock is up 25.5% over the past month.
UMC reports on July 29. The last print, in April, sent the stock up 12% on the day and 30.6% over the following five days. That kind of historical volatility justifies elevated borrow costs ahead of a binary event. Lenders reprice for event risk. The record CTB may partly reflect that calendar dynamic.
BlackRock added 132.4 million shares in the period to June 30, lifting its stake to 7.6% of shares outstanding. That is a significant build from one of the world's largest passive and active managers.
See the live data behind this article on ORTEX.
Open UMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
